5,047
Participants
Start Date
June 27, 2020
Primary Completion Date
March 31, 2024
Study Completion Date
March 31, 2024
Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg
Experimental only, not included active and placebo comparator
Dong-A University Hospital, Busan
Hallym University Sacred Heart Hospital, Anyang-si
Changwon Fatima Hospital, Changwon
Gyeongsang National University Changwon Hospital, Changwon
Daegu Catholic University Medical Center, Daegu
Keimyung University Dongsan Medical Center, Daegu
Yeungnam University Medical Center, Daegu
Daejeon Eulji Medical Center Eulji University, Daejeon
Myungji Hospital, Goyang-si
Chonnam National University Hospital, Gwangju
Chosun University Hospital, Gwangju
Bundang Jesaeng General Hospital, Gyeonggi-do
Cha University Bundang Medical Center, Gyeonggi-do
Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do
Korea University Ansan Hospital, Gyeonggi-do
National Health Insurance Service Ilsan Hospital, Gyeonggi-do
Samsung Changwon Hospital, Gyeongsang
Wonkwang University Hospital, Iksan
Dongguk University Ilsan Hospital, Ilsan
Inje University Ilsan Paik Hospital, Ilsan
Inha University Hospital, Incheon
Kwandong University International St.Mary'S Hospital, Incheon
Soon Chun Hyang University Hospital Cheonan, Jungbuk
Dankook University Hospital, Jungnam
Kwangju Veterance Hospital, Kwangju
Pusan National University Hospital, Pusan
Pusan National University Yangsan Hospital, Pusan
Ewha Womans University Mokdong Hospital, Seoul
Ewha Womans University Seoul Hospital, Seoul
Hallym University Medical Center, Seoul
Kangdong Sacred Heart Hospital, Seoul
Korea University Anam Hospital, Seoul
Korea University Guro Hospital, Seoul
Kyung Hee University Medical Center, Seoul
National Medical Center, Seoul
Samsung Medical Center, Seoul
Ulsan University, Ulsan
Wonju Severance Christian Hospital, Wŏnju
Gangnam Severance Hospital, Seoul
Yuhan Corporation
INDUSTRY